Key Points
- U.S. Health Secretary Robert F. Kennedy Jr. aims for quick wins on health initiatives to aid Republicans in the November 2026 midterms.
- White House instructed pivot from vaccine policy rewrite after widespread criticism.
- Recent efforts include executive order on psychedelics research, approval of gene therapy for rare childhood hearing loss.
- Plans emphasise Trump’s prescription drug price cuts via TrumpRx, food policy initiatives, and potential approvals for childhood disease treatments.
- Kennedy to campaign in competitive congressional districts using his celebrity appeal.
- No further anti-vaccine steps this year ahead of elections, per White House.
- Polls indicate high stakes for Republicans risking loss of Congress control.
- Republican pollster Whit Ayres warns Kennedy’s anti-vaccine associations could harm the party.
Washington (Evening Washington News)May 4, 2026 – Senior administration officials told Reuters that the White House asked Kennedy to pivot from a widely criticised campaign to rewrite U.S. vaccine policy, with new efforts designed to appeal to Trump’s voter base. These include an executive order bolstering research into psychedelics and approving a new gene therapy for children with a rare type of hearing loss.
As reported by Reuters journalists, three people familiar with the matter stated that Trump is keen to stress prescription drug price cuts negotiated by his appointees, while Kennedy’s team plans food policy initiatives and explores quick approvals for other childhood disease treatments. It remains unclear which moves will be selected.
Details of aligning Kennedy’s strategy with White House midterm priorities were revealed for the first time based on interviews with over a dozen current and former senior officials and advisers. This follows months of friction over personnel and policies.
What Recent Health Initiatives Has the Administration Announced?
The executive order on psychedelics, signed by President Trump, directs the removal of regulatory barriers for research and compassionate use via the Federal Right to Try Act, and encourages FDA priority vouchers for psychedelic drugs with Breakthrough Therapy designations for mental health. It allocates $50 million to ARPA-H for research, including ibogaine, and expedites rescheduling for Phase 3 trial successes.
On gene therapy, the FDA approved Otarmeni (lunsotogene parvec-cwha), the first dual AAV vector-based treatment for severe-to-profound hearing loss linked to OTOF gene variants in children and adults, under the National Priority Voucher program.
The FDA called it groundbreaking, with approval 61 days after filing, following New England Journal of Medicine results showing hearing restoration in patients.
TrumpRx provides discounts on brand-name drugs, with Kennedy defending Trump’s claim of a “600% reduction” from $600 to $10 as a different calculation method during a Senate Finance Committee hearing, as grilled by Senator Elizabeth Warren.
Food initiatives under Kennedy’s “Eat Real Food” push promote nutritious food as attainable, featuring celebrities like Mike Tyson, and address chronic diseases via nutrition, chemicals, activity, and overmedicalization, per the MAHA Commission report.
How Is Kennedy’s Past Vaccine Stance Impacting Midterm Strategy?
Polls show Republicans risk losing Congress control, with Kennedy’s moves like removing vaccines from the childhood schedule potentially harming candidates. Four senior officials said the White House insisted on no more anti-vaccine steps this year.
A court halted Kennedy’s vaccine overhaul, invalidating ACIP restructure and schedule cuts from 17 to 11 diseases, after White House retreat due to polling showing vaccine skepticism as bad politics. In a congressional hearing, Kennedy testified the measles vaccine is safe and effective for most, safer than the disease.
One senior official noted Kennedy has “a good grasp” on election politics and a list of non-contentious options. Yet, Republican pollster Whit Ayres, as quoted by Reuters, warned:
“The vast majority of Americans view effective vaccines as one of the great miracles of modern medicine. An anti-vaccine message is political poison.”
Ayres added:
“Kennedy is trying to be a team player, but he is so widely associated with an anti-vaccine message that I don’t know that he can effectively pivot away from that.”
What Role Will RFK Jr. Play in the Midterm Campaign?
Three senior officials said the White House views Kennedy’s celebrity status and appeal to non-Republican voters as an asset. He will join the campaign in competitive districts over coming months.
Ads by 314 Action link vulnerable Republicans like Reps. Miller-Meeks (IA-01), Mackenzie (PA-07), Kiggans (VA-02), Evans (CO-08), and Kiley (CA-03) to Kennedy’s policies ahead of budget hearings.
Kennedy hosted a high-profile “Eat Real Food” event and plans nutrition focus in hearings, avoiding vaccines. The White House tasked him with nationwide promotion of real food and activity to combat obesity and diabetes.
Background of the Development
Robert F. Kennedy Jr. was appointed U.S. Health Secretary in early 2025 after President Trump’s reelection. His initial focus included MAHA initiatives targeting childhood chronic diseases through nutrition, toxins, activity, and reduced overmedicalization, with actions like calling for removal of artificial dyes and reviewing food additives.
Vaccine policy changes, such as ACIP overhaul and schedule cuts, faced legal blocks and political pushback by early 2026. Amid midterm pressures, the administration shifted to popular measures like psychedelics access for veterans’ PTSD, gene therapies, drug pricing, and food reforms, as detailed in executive orders and FDA actions from April 2026. This pivot reflects internal tensions resolved through strategic realignment.
Prediction: How This Can Affect Republican Voters
This development can provide Republican voters with tangible health policy advancements, such as faster access to psychedelics for mental health, gene therapies for rare conditions, discounted drugs via TrumpRx, and food initiatives targeting chronic diseases.
Campaign appearances by Kennedy in key districts may boost turnout among his supporters. Avoidance of vaccine controversies could mitigate polling risks, allowing focus on issues like drug costs and nutrition appealing to the base. Outcomes depend on voter reception of these initiatives ahead of November elections.
